Kadence Bio is a clinical-stage life sciences company developing novel treatments for sexual and mental health conditions.
Kadence Bio has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in June 2025.
Kadence Bio is headquartered in London, United Kingdom.
Kadence Bio is a clinical-stage life sciences company developing novel treatments for sexual and mental health conditions.
Kadence Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kadence Bio — Funding & Investors." VCBacked, June 1, 2025, https://www.vcbacked.co/company/kadence-bio. Accessed September 29, 2026.
VCBacked. (2025). Kadence Bio — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/kadence-bio
{{cite web |title=Kadence Bio — Funding & Investors |url=https://www.vcbacked.co/company/kadence-bio |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated